Makary commits to review FDA staff cuts, VRBPAC cancelation in Senate confirmation hearing

Regulatory NewsRegulatory NewsAdvisory committeesBiologics/ biosimilars/ vaccinesGovernment/legislationMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)